SEC Comment Letter 0000000000-24-003197 to INTELLIGENT BIO SOLUTIONS INC. (INBS)
INTELLIGENT BIO SOLUTIONS INC.
Date: March 25, 2024 · CIK: 0001725430 · Accession: 0000000000-24-003197
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-278025
Letter
United States securities and exchange commission logo March 22, 2024 Harry Simeonidis Chief Executive Officer Intelligent Bio Solutions Inc. 142 West 57th Street, 11th Floor New York, NY 10019 Re:Intelligent Bio Solutions Inc. Registration Statement on Form S-3 Filed March 18, 2024 File No. 333-278025 Dear Harry Simeonidis: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Juan Grana at 202-551-6034 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Johnathan Duncan, Esq.
Show Raw Text
United States securities and exchange commission logo
March 22, 2024
Harry Simeonidis
Chief Executive Officer
Intelligent Bio Solutions Inc.
142 West 57th Street, 11th Floor
New York, NY 10019
Re:Intelligent Bio Solutions Inc.
Registration Statement on Form S-3
Filed March 18, 2024
File No. 333-278025
Dear Harry Simeonidis:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Juan Grana at 202-551-6034 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Johnathan Duncan, Esq.